Live Breaking News & Updates on Ineta Kurs

Stay updated with breaking news from Ineta kurs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kineta Announces Restructuring and Exploration of Strategic Alternatives

29.02.2024 - SEATTLE, Feb. 29, 2024 (GLOBE NEWSWIRE) - Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it has . Seite 1 ....

Shawn Iadonato , Pauline Kenny , Kineta Inc , Chief Executive Officer , General Counsel , Kineta Chart , Ineta Kurs , Ineta Aktie ,

Kineta Announces Positive KVA12123 Monotherapy Safety and Biomarker Data from its Ongoing Phase 1/2 VISTA-101 Clinical Trial

03.10.2023 - Cleared First Three Monotherapy Cohorts with No Dose Limiting Toxicity and No Consistent Pattern of Adverse Events at any Dose Level ....

Shawn Iadonato , Kineta Inc , Chief Executive Officer , Kineta Chart , Ineta Kurs , Ineta Aktie ,

Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy

25.09.2023 - SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) - Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it will . Seite 1 ....

United States , Thierry Guillaudeux , Kineta Inc , American Association For Cancer Research , American Association , Cancer Research , Special Conference , Tumor Immunology , Chief Scientific Officer , Poster Session , Metropolitan Ballroom , Kineta Chart , Ineta Kurs , Ineta Aktie ,